media centre
Join us @ Keystone! March 24-28 Innate and Non-Classical Immune Cells in Cancer Immunotherapy
20 February
media centre
All media
All media
Twitter
Feed
news
news
publications
publications
schedule
schedule
Only 10 days till the first @KeystoneSym...
Congratulations to our CSO for winning the 2019 Jacques Miller Medal
Well deserved recognition. Congrats to o...
Join us @ Keystone! March 24-28 Innate and Non-Classical Immune Cells in Cancer Immunotherapy
Amazing response to the @KeystoneSymp th...
@LorneCancer conference starts today. Se...
He eats, sleeps, breathes and drives NKC...
31st Annual Lorne Cancer Conference
The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
We are LIVE! https://t.co/fu8vunDAEv Ch...
Did you know that NK cells can recognize...
RT @JoeCursons: Off to a flying start fo...
RT @JohnCendpts: Bristol-Myers inks a $7...
A tremendous study by the Gebhardt group...
Abstract deadline for #innate #immunothe...
Congrats @Dr_Nick_Bikes https://t.co/h5m...
A well deserved congratulations to our f...
New work from our founders. Ablating NK ...
RT @MadsDegnbol: This article describes ...
just mind boggling how this could happen...
Really looking forward to Lorne Cancer C...
This approach will accelerate NK cell #i...
when a peer review journal is committed ...
https://t.co/rDNsOFyJkv
Some great opportunities here. @Malmberg...
Pretty cool tech. Off-the-shelf is the w...
Great line-up ;-) Well done @DGCarnegie ...
https://t.co/M8iBYlcu0r https://t.co/cL4...
New speakers added to the program for th...
https://t.co/vr4psigU4D
@oNKo_innate founders getting behind @Ca...
The excitement surrounding NK cell immun...
#companygoals https://t.co/iZKmcqtHqM
Welcome to our new website!
RT @Immunopole: When is a #neoantigen no...